Delaware legislation · 153rd General Assembly
Delaware SB319: Menopause/Diagnostic Services/Treatments/Insurance/Require
Status: Signed into law, September 8, 2026
AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO COVERAGE FOR DIAGNOSTIC SERVICES AND TREATMENT FOR MENOPAUSE, PERIMENOPAUSE, AND MENOPAUSE AND PERIMENOPAUSE SYMPTOMS.
What the bill says
An act to amend title 18, title 29, and title 31 of the delaware code relating to coverage for diagnostic services and treatment for menopause, perimenopause, and menopause and perimenopause symptoms.
From the introduced text, May 13, 2026:
AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO COVERAGE FOR DIAGNOSTIC SERVICES AND TREATMENT FOR MENOPAUSE, PERIMENOPAUSE, AND MENOPAUSE AND PERIMENOPAUSE SYMPTOMS. Section 1. Amend Chapter 33, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows: § 3370N. Coverage for diagnostic services and treatment for menopause and perimenopause. (a) As used in this section: (1) "Hormone replacement therapy" means medical treatment that replaces a hormone that an individual's body is no longer making or no longer making enough of, as determined by a licensed health-care professional. "Hormone replacement therapy" includes prescribing any of the following: a. A cream. b. An oral medication. c. A pellet medication. d. A vaginal device. e. Another method approved by the United States Food and Drug Administration. (2) "Medically necessary" means providing of health-care services or products that a prudent licensed health-care professional would provide to a patient for the purpose of diagnosing or treating menopause, perimenopause, menopause and perimenopause symptoms, and conditions associated with menopause or perimenopause in a manner that is all of the following: a. In accordance with generally accepted standards of medical practice. b. Consistent with the symptoms or treatment of the condition. c. Not solely for anyone's convenience. …
Sponsors
- Nicole Poore (D, 12) · primary sponsor
- Kamela Smith (D, 15)
- Kyra Hoffner (D, 14)
- Marie Pinkney (D, 13)
- Laura Sturgeon (D, 4)
- Alonna Berry (D, 20)
- Frank Burns (D, 21)
- Mara Gorman (D, 23)
- Debra Heffernan (D, 6)
- Eric Morrison (D, 27)
- DeShanna Neal (D, 13)
- Cyndie Romer (D, 25)
Latest actions
- : SS 1 for SB 319 - Signed by Governor
- : SS 1 for SB 319 - Passed By House. Votes: 36 YES 1 NO 4 ABSENT
- : SS 1 for SB 319 - Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 8 On Its Merits
- : SS 1 for SB 319 - Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
- : SS 1 for SB 319 - Passed By Senate. Votes: 21 YES
- : Substituted in Senate by SS 1 for SB 319
- : Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable
- : Introduced and Assigned to Health & Social Services Committee in Senate
Votes
- Passed (2/3) (June 25, 2026): 36 yea, 1 nay, passed
- Passed (2/3) (June 17, 2026): 21 yea, 0 nay, passed
Common questions
- What is SB319?
- SB319 is a bill in the Delaware Legislature (153rd General Assembly): Menopause/Diagnostic Services/Treatments/Insurance/Require.
- What does SB319 do?
- In its own words: An act to amend title 18, title 29, and title 31 of the delaware code relating to coverage for diagnostic services and treatment for menopause, perimenopause, and menopause and perimenopause symptoms.
- What is the status of SB319?
- Signed into law as of September 8, 2026. Latest action: SS 1 for SB 319 - Signed by Governor (September 8, 2026).
- Who sponsored SB319?
- Nicole Poore (D, 12), with 11 co-sponsors.
- Where is the official record for SB319?
- On the Delaware Legislature website: https://legis.delaware.gov/BillDetail?LegislationId=143298
Source: official Delaware record. Tracked by Delilah, AI for legislation across all 50 states and Congress.